女性骨盤インプラント市場：製品タイプ、適応症、エンドユーザー別-2025-2030年の世界予測

女性骨盤インプラント市場は、2023年に9億7,232万米ドルと評価され、2024年には10億1,559万米ドルに達すると予測され、CAGR 4.76%で成長し、2030年には13億4,729万米ドルに達すると予測されています。

女性骨盤インプラント市場は、より広範な医療機器業界の中でも特殊なセグメントであり、骨盤臓器脱（POP）やストレス性尿失禁（SUI）などの症状に対処するために設計された製品に焦点を当てています。これらのインプラントは、高齢化、肥満、出産の影響などの要因によるこれらの症状の有病率の増加のため、非常に重要です。用途は主に、弱くなった骨盤底構造をサポートするための外科的処置であり、エンドユーザーには病院、婦人科クリニック、専門外科センターなどが含まれます。市場成長は、インプラントの生体適合性と耐用年数を向上させる材料科学における技術的進歩と、患者における外科手術の選択肢に対する認識と受容の高まりによって推進されます。ヘルスケア支出の増加と政府の支援策も、市場の拡大にプラスに寄与しています。

しかし、市場は厳しい規制基準やインプラント後の合併症といった課題に直面しており、これはメーカーと消費者の双方に抑止力を与えています。製品の不具合に関する否定的な報道や訴訟が消費者の信頼を損なうこともあり、市場の監視が強まっています。こうした課題にもかかわらず、アンメット・メディカル・ニーズのある新興国をターゲットとし、患者の予後を改善する低侵襲手術技術を進歩させるという機会は存在します。技術革新の主な分野は、高度な生体材料と、リアルタイムのモニタリングと調整が可能なスマート技術を活用した次世代インプラントの開発にあります。調査は、既存製品の安全性プロファイルの改善と、回復時間を短縮し長期的な有効性を高める新しいソリューションの開拓の両方に焦点を当てるべきです。

市場の特性という点では、競合情勢は継続的な研究開発に牽引され、企業は医療提供者との強い協力関係を育み、市場の信頼を強化するための教育イニシアチブに投資する必要があります。企業は、患者中心の設計と、製品の性能と患者の満足度を追跡するための強固な市販後調査システムを優先させることで、成長を生かすことができます。その結果、研究機関との提携や臨床試験への参入に注力することで、このダイナミックな市場環境において優位に立つことができます。

市場力学：急速に進化する女性骨盤インプラント市場における主要市場インサイトの解明

女性骨盤インプラント市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 女性の骨盤障害の増加、女性の生殖と全身の健康に対する意識の高まり
  • 女性のヘルスケアと医療サービスへのアクセスを拡大するための政府の取り組み
• 市場抑制要因
  • 規制状況を乗り切ることの難しさと訴訟の発生
• 市場機会
  • 安全性、性能、機能性に優れた女性骨盤インプラントの開発における継続的な進歩
  • 手術センターや不妊治療クリニックの世界の拡大
• 市場の課題
  • 十分な訓練を受けた外科医の不足と性能の問題

ポーターのファイブフォース：女性骨盤インプラント市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：女性骨盤インプラント市場における外部からの影響の把握

外部マクロ環境要因は、女性骨盤インプラント市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析女性骨盤インプラント市場における競合情勢の把握

女性骨盤インプラント市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス女性骨盤インプラント市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、女性骨盤インプラント市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨女性骨盤インプラント市場における成功への道筋を描く

女性骨盤インプラント市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 女性の骨盤疾患の発生率の増加と女性の生殖および全体的な健康に関する意識
    • 女性のヘルスケアと医療サービスへのアクセスを拡大するための政府の取り組み
  • 抑制要因
    • 規制状況への対応の難しさと訴訟の発生
  • 機会
    • 安全性、パフォーマンス、機能が向上した女性骨盤インプラントの開発が継続的に進歩しています
    • 世界中で外科センターと不妊治療クリニックを拡大
  • 課題
    • 十分な訓練を受けた外科医の不足とパフォーマンスの問題
• 市場セグメンテーション分析
  • 製品タイプ：腹圧性尿失禁の治療に効果があることから膣スリングの使用が拡大
  • エンドユーザー：病院の総合的な設備と幅広い専門医の配置により、女性骨盤インプラントの採用が拡大しています。
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 女性骨盤インプラント市場：製品タイプ別

• 膣移植インプラント
• 膣メッシュインプラント
• 膣スリング

第7章 女性骨盤インプラント市場適応症別

• 骨盤臓器脱
• 腹圧性尿失禁

第8章 女性骨盤インプラント市場：エンドユーザー別

• 外来手術センター
• 病院
• 専門クリニック

第9章 南北アメリカの女性骨盤インプラント市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の女性骨盤インプラント市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの女性骨盤インプラント市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • カルデラメディカル、プレミア社と女性医療および外科的失禁の専門契約を締結
  • CurvaFix、骨盤骨折治療用の湾曲手術機器の強化に向け3,900万米ドルを調達
  • FemTherapeuticsが患者固有の婦人科用義肢で女性の健康を促進するために180万米ドルを調達
• 戦略分析と提言

企業一覧

• Advin Urology
• B. Braun of America Inc.
• Betatech Medical
• Boston Scientific Corporation
• Caldera Medical
• CARDIOLINK S.L. by CB Scientific, Inc.
• Coloplast Corp.
• Cook Group Incorporated
• CurvaFix, Inc.
• Medtronic
• Narang Medical Limited
• Neomedic Int
• Olympus Corporation
• PALEX MEDICAL, S.A
• pfm Medical GmbH
• PROMEDON GmbH
• SARS Cousin Biotech
• Tecomet, Inc.
• Zimmer Biomet
• ZSI Surgical Implants S.R.L.

LIST OF FIGURES

• FIGURE 1. FEMALE PELVIC IMPLANTS MARKET RESEARCH PROCESS
• FIGURE 2. FEMALE PELVIC IMPLANTS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. FEMALE PELVIC IMPLANTS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. FEMALE PELVIC IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. FEMALE PELVIC IMPLANTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. FEMALE PELVIC IMPLANTS MARKET DYNAMICS
• TABLE 7. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY VAGINAL GRAFT IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY VAGINAL MESH IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY VAGINAL SLING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY PELVIC ORGAN PROLAPSE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY STRESS URINARY INCONTINENCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 28. CANADA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 29. CANADA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 30. CANADA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. CHINA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 46. CHINA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 47. CHINA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 48. INDIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 49. INDIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 50. INDIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. ITALY FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 101. ITALY FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 102. ITALY FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 112. POLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 113. POLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 114. POLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 115. QATAR FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 116. QATAR FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 117. QATAR FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 145. FEMALE PELVIC IMPLANTS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 146. FEMALE PELVIC IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2023

The Female Pelvic Implants Market was valued at USD 972.32 million in 2023, expected to reach USD 1,015.59 million in 2024, and is projected to grow at a CAGR of 4.76%, to USD 1,347.29 million by 2030.

The market for female pelvic implants is a specialized segment within the broader medical devices industry, focusing on products designed to address conditions like pelvic organ prolapse (POP) and stress urinary incontinence (SUI). These implants are crucial due to the increasing prevalence of these conditions, often attributed to factors such as aging populations, obesity, and childbirth effects. Applications primarily involve surgical procedures to provide support to weakened pelvic floor structures, with end-users including hospitals, gynecological clinics, and specialized surgical centers. Market growth is propelled by technological advancements in material sciences, improving implant biocompatibility and longevity, alongside increasing awareness and acceptance of surgical options among patients. Rising healthcare expenditure, coupled with supportive government initiatives, also contributes positively to market expansion.

However, the market faces challenges such as stringent regulatory standards and post-implant complications, which can deter both manufacturers and consumers. Negative media coverage and litigation related to product failures have sometimes undermined consumer confidence, intensifying market scrutiny. Despite these challenges, opportunities exist in targeting emerging economies with unmet medical needs and advancing minimally invasive surgical techniques that offer better patient outcomes. A key area for innovation lies in developing next-generation implants utilizing advanced biomaterials and smart technology capable of real-time monitoring and adjustments. Research should focus on both improving the safety profile of existing products and pioneering new solutions that reduce recovery times and enhance long-term efficacy.

In terms of market nature, female pelvic implants remain a competitive landscape driven by continuous R&D, requiring companies to foster strong collaborative ties with healthcare providers and invest in educational initiatives to reinforce market trust. Companies can capitalize on growth by prioritizing patient-centric designs and robust post-market surveillance systems to track product performance and patient satisfaction. Consequently, focusing on partnerships with research institutions and participating in clinical trials can provide an edge in this dynamic market environment.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Female Pelvic Implants Market

The Female Pelvic Implants Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidences of pelvic disorders among women and awareness about women's reproductive and overall health
  • Government initiatives to expand access to healthcare and medical services for women
• Market Restraints
  • Difficulties in navigating the regulatory landscape and incidences of lawsuits
• Market Opportunities
  • Ongoing advancements in developing female pelvic implants with better safety, performance, and functional features
  • Expansion of surgical centers and fertility clinics across the world
• Market Challenges
  • Shortage of adequately trained surgeons and performance issues

Porter's Five Forces: A Strategic Tool for Navigating the Female Pelvic Implants Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Female Pelvic Implants Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Female Pelvic Implants Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Female Pelvic Implants Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Female Pelvic Implants Market

A detailed market share analysis in the Female Pelvic Implants Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Female Pelvic Implants Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Female Pelvic Implants Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Female Pelvic Implants Market

A strategic analysis of the Female Pelvic Implants Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Female Pelvic Implants Market, highlighting leading vendors and their innovative profiles. These include Advin Urology, B. Braun of America Inc., Betatech Medical, Boston Scientific Corporation, Caldera Medical, CARDIOLINK S.L. by CB Scientific, Inc., Coloplast Corp., Cook Group Incorporated, CurvaFix, Inc., Medtronic, Narang Medical Limited, Neomedic Int, Olympus Corporation, PALEX MEDICAL, S.A, pfm Medical GmbH, PROMEDON GmbH, SARS Cousin Biotech, Tecomet, Inc., Zimmer Biomet, and ZSI Surgical Implants S.R.L..

Market Segmentation & Coverage

This research report categorizes the Female Pelvic Implants Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Vaginal Graft Implants, Vaginal Mesh Implants, and Vaginal Sling.
• Based on Indication, market is studied across Pelvic Organ Prolapse and Stress Urinary Incontinence.
• Based on End User, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidences of pelvic disorders among women and awareness about women's reproductive and overall health
    • 5.1.1.2. Government initiatives to expand access to healthcare and medical services for women
  • 5.1.2. Restraints
    • 5.1.2.1. Difficulties in navigating the regulatory landscape and incidences of lawsuits
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing advancements in developing female pelvic implants with better safety, performance, and functional features
    • 5.1.3.2. Expansion of surgical centers and fertility clinics across the world
  • 5.1.4. Challenges
    • 5.1.4.1. Shortage of adequately trained surgeons and performance issues
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product Type: Expanding usage of vaginal sling due to its efficacy in treating stress urinary incontinence
  • 5.2.2. End User: Emerging adoption of female pelvic implants by hospitals owing to their comprehensive facilities and wide range of specialists
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Female Pelvic Implants Market, by Product Type

• 6.1. Introduction
• 6.2. Vaginal Graft Implants
• 6.3. Vaginal Mesh Implants
• 6.4. Vaginal Sling

7. Female Pelvic Implants Market, by Indication

• 7.1. Introduction
• 7.2. Pelvic Organ Prolapse
• 7.3. Stress Urinary Incontinence

8. Female Pelvic Implants Market, by End User

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Hospitals
• 8.4. Specialty Clinics

9. Americas Female Pelvic Implants Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Female Pelvic Implants Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Female Pelvic Implants Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Caldera Medical awarded Specialty Women's Health and Surgical Incontinence contract Agreement with Premier Inc
  • 12.3.2. CurvaFix lands USD 39 million to boost curved surgical device used for pelvic fracture treatment
  • 12.3.3. FemTherapeutics Raises USD 1.8 Million To Advance Women's Health With Its Patient-Specific Gynecological Prosthetics
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Advin Urology
• 2. B. Braun of America Inc.
• 3. Betatech Medical
• 4. Boston Scientific Corporation
• 5. Caldera Medical
• 6. CARDIOLINK S.L. by CB Scientific, Inc.
• 7. Coloplast Corp.
• 8. Cook Group Incorporated
• 9. CurvaFix, Inc.
• 10. Medtronic
• 11. Narang Medical Limited
• 12. Neomedic Int
• 13. Olympus Corporation
• 14. PALEX MEDICAL, S.A
• 15. pfm Medical GmbH
• 16. PROMEDON GmbH
• 17. SARS Cousin Biotech
• 18. Tecomet, Inc.
• 19. Zimmer Biomet
• 20. ZSI Surgical Implants S.R.L.